Intermediate HER2 expression is associated with poor prognosis in estrogen receptor-positive breast cancer patients aged 55 years and older

被引：0
|
作者：
Min Hwan Kim
Gun Min Kim
Jee Hung Kim
Jee Ye Kim
Hyung Seok Park
Seho Park
Young Up Cho
Byeong Woo Park
Seung Il Kim
Joohyuk Sohn
机构：
[1] Yonsei University College of Medicine,Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center
[2] Gangnam Severance Hospital,Division of Medical Oncology, Department of Internal Medicine
[3] Yonsei University College of Medicine,Division of Breast Surgery, Department of Surgery, Yonsei Cancer Center
[4] Yonsei University College of Medicine,undefined
来源：
Breast Cancer Research and Treatment | 2020年 / 179卷
关键词：
Intermediate HER2; Age; Prognosis; Metastatic breast cancer; Early breast cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：687 / 697
页数：10
相关论文
共 50 条
  • [41] The association between the expression of progesterone receptor and clinical benefit of adjuvant trastuzumab in estrogen receptor-positive and HER2-positive breast cancer patients
    Lee, H. W.
    Ahn, S. G.
    Park, J. T.
    Yang, B. S.
    Park, S.
    Jeong, J.
    Kim, S. I.
    CANCER RESEARCH, 2016, 76
  • [42] Impact of hormonal receptor status on prognosis in HER2 positive breast cancer
    Cantini, L.
    Pistelli, M.
    Paesani, M.
    Ballatore, Z.
    Bastianelli, L.
    De Lisa, M. G.
    Santoni, M.
    Pagliacci, A.
    Battelli, N.
    Bracci, R.
    Maccaroni, E.
    Valeri, I.
    Biscotti, T.
    Santinelli, A.
    Berardi, R.
    ANNALS OF ONCOLOGY, 2016, 27
  • [43] Systemic Therapy for Estrogen Receptor-Positive, HER2-Negative Breast Cancer
    Burstein, Harold J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (12): : 1176 - 1177
  • [44] Systemic Therapy for Estrogen Receptor-Positive, HER2-Negative Breast Cancer
    Burstein, Harold J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (26): : 2557 - 2570
  • [45] Developing a patient decision aid for women aged 70 and older with early stage, estrogen receptor positive, HER2 negative, breast cancer
    Schonberg, Mara A.
    Freedman, Rachel A.
    Recht, Abram R.
    Jacobson, Alicia R.
    Aliberti, Gianna M.
    Karamourtopoulos, Maria
    Nakhlis, Faina
    McCarthy, Ellen P.
    Pories, Susan E.
    Sharma, Ranja
    Dominici, Laura S.
    JOURNAL OF GERIATRIC ONCOLOGY, 2019, 10 (06) : 980 - 986
  • [46] Co-expression of SNAIL and TWIST determines prognosis in estrogen receptor-positive early breast cancer patients
    van Nes, Johanna G. H.
    de Kruijf, Esther M.
    Putter, Hein
    Faratian, Dana
    Munro, Alison
    Campbell, Fiona
    Smit, Vincent T. H. B. M.
    Liefers, Gerrit-Jan
    Kuppen, Peter J. K.
    van de Velde, Cornelis J. H.
    Bartlett, John M. S.
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 133 (01) : 49 - 59
  • [47] HER2 and hormone receptor-positive breast cancer-blocking the right target
    Cortes, Javier
    Saura, Cristina
    Bellet, Meritxell
    Munoz-Couselo, Eva
    Ramirez-Merino, Natalia
    Calvo, Virginia
    Perez, Jose
    Vidal, Maria
    NATURE REVIEWS CLINICAL ONCOLOGY, 2011, 8 (05) : 307 - 311
  • [48] AGR2 associates with HER2 expression predicting poor outcome in subset of estrogen receptor negative breast cancer patients
    Ondrouskova, Eva
    Sommerova, Lucia
    Nenutil, Rudolf
    Coufal, Oldrich
    Bouchal, Pavel
    Vojtesek, Borivoj
    Hrstka, Roman
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2017, 102 (02) : 280 - 283
  • [49] HER2 overexpression and activation, and tamoxifen efficacy in receptor-positive early breast cancer
    Christian F. Singer
    Daphne Gschwantler-Kaulich
    Anneliese Fink-Retter
    Georg Pfeiler
    Ingrid Walter
    Gernot Hudelist
    Samir Helmy
    Anne-Catherine Spiess
    Wolfgang Lamm
    Ernst Kubista
    Journal of Cancer Research and Clinical Oncology, 2009, 135 : 807 - 813
  • [50] The impact of CBP expression in estrogen receptor-positive breast cancer
    Wafaa S. Ramadan
    Iman M. Talaat
    Mahmood Y. Hachim
    Annette Lischka
    Timo Gemoll
    Raafat El-Awady
    Clinical Epigenetics, 2021, 13
12345